Your browser doesn't support javascript.
loading
Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.
Ambrose, Nalini; Amin, Alpesh; Anderson, Brian; Barrera-Oro, Julio; Bertagnolli, Monica; Campion, Francis; Chow, Daniel; Danan, Risa; D'Arinzo, Lauren; Drews, Ashley; Erlandson, Karl; Fitzgerald, Kristin; Garcia, Melissa; Gaspar, Fraser W; Gong, Carlene; Hanna, George; Jones, Stephen; Lopansri, Bert; Musser, James; O'Horo, John; Piantadosi, Steven; Pritt, Bobbi; Razonable, Raymund R; Roberts, Seth; Sandmeyer, Suzanne; Stein, David; Vahidy, Farhaan; Webb, Brandon; Yttri, Jennifer.
Afiliación
  • Ambrose N; The MITRE Corporation, Bedford, Massachusetts.
  • Amin A; Department of Medicine, University of California, Irvine.
  • Anderson B; Hospital Medicine Program, University of California, Irvine.
  • Barrera-Oro J; The MITRE Corporation, Bedford, Massachusetts.
  • Bertagnolli M; Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, District of Columbia.
  • Campion F; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Chow D; The MITRE Corporation, Bedford, Massachusetts.
  • Danan R; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
  • D'Arinzo L; Department of Radiological Sciences, University of California, Irvine.
  • Drews A; The MITRE Corporation, Bedford, Massachusetts.
  • Erlandson K; The MITRE Corporation, Bedford, Massachusetts.
  • Fitzgerald K; Division of Infectious Diseases, Department of Medicine, Houston Methodist, Houston, Texas.
  • Garcia M; Houston Methodist Academic Institute, Houston, Texas.
  • Gaspar FW; Weill Cornell Medical College, New York, New York.
  • Gong C; Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, District of Columbia.
  • Hanna G; The MITRE Corporation, Bedford, Massachusetts.
  • Jones S; The MITRE Corporation, Bedford, Massachusetts.
  • Lopansri B; The MITRE Corporation, Bedford, Massachusetts.
  • Musser J; Booz Allen Hamilton in support of BARDA, Washington, District of Columbia.
  • O'Horo J; Tunnell Government Services in support of BARDA, Princeton, New Jersey.
  • Piantadosi S; Center for Health Data Science and Analytics, Houston Methodist, Houston, Texas.
  • Pritt B; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Murray, Utah.
  • Razonable RR; Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City.
  • Roberts S; Laboratory of Molecular and Translational Human Infectious Disease Research, Center for Infectious Diseases, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute and Houston Methodist Hospital, Houston, Texas.
  • Sandmeyer S; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York.
  • Stein D; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York.
  • Vahidy F; Center for Individualized Medicine-Mayo Clinic Research, Rochester, Minnesota.
  • Webb B; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Yttri J; Center for Individualized Medicine-Mayo Clinic Research, Rochester, Minnesota.
JAMA Netw Open ; 6(4): e239694, 2023 04 03.
Article en En | MEDLINE | ID: mdl-37093599
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged / Newborn Idioma: En Revista: JAMA Netw Open Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged / Newborn Idioma: En Revista: JAMA Netw Open Año: 2023 Tipo del documento: Article